UBS maintains Buy on Ulta Beauty stock, target at $490

Published 02/04/2025, 15:20
UBS maintains Buy on Ulta Beauty stock, target at $490

On Wednesday, UBS analysts maintained a positive outlook on Ulta Beauty (NASDAQ: NASDAQ:ULTA) shares, reiterating their Buy rating and a price target of $490.00. The $17.2 billion beauty retailer, currently trading at $380.23, has maintained a strong financial health score of "GREAT" according to InvestingPro data. The firm’s analysts highlighted several key factors supporting their stance on the beauty retailer’s stock. They noted that recent data suggests Ulta’s market share is showing signs of stabilization, though InvestingPro data shows 25 analysts have revised their earnings expectations downward for the upcoming period. Additionally, the analysts observed that the Sephora rollout within Kohl’s (NYSE:KSS) stores has likely reached the peak of its impact on Ulta’s sales, implying that any negative effects from this competition may have already been fully realized. Discover more valuable insights about Ulta Beauty and 1,400+ other stocks with InvestingPro’s comprehensive research reports.

UBS further commented on the tariff situation, stating that after reviewing the sourcing and manufacturing footprint of major beauty brands, they believe tariffs should be manageable for Ulta. This assessment could ease concerns about potential cost increases for the retailer due to international trade policies.

Moreover, the analysts pointed to the resilience of the beauty category during economic downturns, citing its performance in previous challenging market conditions. This resilience suggests that Ulta may be better positioned than other retailers to weather any potential economic headwinds.

Lastly, UBS analysts mentioned that Ulta Beauty’s stock is currently trading at a valuation slightly above 15 times the next twelve months’ consensus earnings estimates, which they view as achievable. This aligns with the current P/E ratio of 14.92x, and notably, InvestingPro’s Fair Value analysis suggests the stock is slightly undervalued. With a robust return on equity of 50% and steady revenue growth of 0.79%, these factors support expectations for potential price appreciation.

Investors and market watchers will likely monitor Ulta Beauty’s performance closely, considering UBS’s reiterated Buy rating and the outlined reasons suggesting the company’s continued growth potential in the beauty retail sector.

In other recent news, ULTA Beauty’s financial performance has been a focal point for analysts. The company reported a strong earnings beat, with a 19% increase in earnings per share (EPS) driven by comparable store sales that exceeded expectations. However, guidance for fiscal year 2025 and 2026 indicates lower-than-expected EPS and revenue growth, suggesting a transitional period for the company. In response to these developments, Goldman Sachs upgraded ULTA Beauty’s stock rating from Neutral to Buy, raising the price target to $423, citing strong sales momentum and favorable valuation.

Conversely, TD Cowen and Piper Sandler adjusted their price targets to $400 and $364, respectively, maintaining a Hold and Neutral rating. Both firms highlighted the challenges ULTA faces, including competition from Sephora and Amazon (NASDAQ:AMZN), and the need for strategic improvements in product offerings and digital advertising. BMO Capital also revised its price target to $404 while maintaining a Market Perform rating, noting ULTA’s strong sales and EPS but expressing caution due to competitive pressures and the company’s guidance.

These recent developments reflect a mixed outlook for ULTA Beauty, with some analysts expressing optimism about long-term prospects while others remain cautious about near-term challenges. The focus remains on ULTA’s strategic initiatives to improve market share and margin progression in a competitive landscape.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.